Childhood Cancer Data Initiative Data Ecosystem Platforms and Tools
A range of childhood cancer data platforms and tools will be available as part of the Childhood Cancer Data Initiative (CCDI) Data Ecosystem. These resources are being created and connected to make it easier to locate and use data that could help advance childhood cancer research.
As the CCDI Data Ecosystem is further developed, information about more platforms and tools will be added.
CCDI National Childhood Cancer Registry
The CCDI National Childhood Cancer Registry (NCCR) is a rapidly growing public data resource on childhood, adolescent, and young adult cancer statistics. NCCR data come from hospitals, research centers, health care administrations, and other sources and are accessible through NCCR*Explorer. NCCR’s primary goal is to collect data from children, adolescents, and young adults with cancer—regardless of where they receive care—to better understand the causes, outcomes, effective treatments, and late effects of childhood cancer. This resource will enhance access to and use of childhood cancer and survivorship data, allowing researchers to answer important questions needed to improve outcomes and track clinical trial participation.
CCDI Childhood Cancer Data Catalog
The CCDI Childhood Cancer Data Catalog is an inventory of childhood cancer data repositories from across the childhood cancer research community. This catalog will make it easier for researchers, doctors, and citizen scientists to find data that will help them. Each resource page includes a summary description, data content types, and links to access the data. The inventory includes childhood cancer repositories, registries, data commons, websites, tools, and catalogs that manage and refer to data.
CCDI Molecular Targets Platform
The CCDI Molecular Targets Platform is a tool that provides information about molecular targets—molecules involved in the growth and spread of cancer cells—that specifically affect childhood cancers. The platform includes information sourced from the Food and Drug Administration’s Pediatric Molecular Target Lists and several other projects, with plans to add more sources.